Long-Acting Methylphenidate Has an Effect on Aggressive Behavior in Children with Attention-Deficit/Hyperactivity Disorder

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  2007-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.2007.0011PMID 17822338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lassen sich hyperkinetische Auffälligkeiten am Nachmittag durch eine Morgengabe von Methylphenidat Retard vermindern

  2004influential reference
• Comparative efficacy of once–a–day extended–release methylphenidate, two–times–daily immediate–release methylphenidate, and placebo in a laboratory school setting

  2004cited by this paper
• [Does a morning dose of Methylphenidate Retard reduce hyperkinetic symptoms in the afternoon?].

  2004cited by this paper
• Effectiveness of an adaptive multimodal treatment in children with Attention–Deficit Hyperactivity Disorder – global outcome

  2004cited by this paper
• Langzeitwirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen

  2003influential reference
• Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

  2003cited by this paper
• Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder

  2003cited by this paper
• Drug treatment of conduct disorder in young people.

  2002cited by this paper
• Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

  2002cited by this paper
• [Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)].

  2002cited by this paper
• Evidenzbasierte Therapie von Kindern und Jugendlichen mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS)

  2002cited by this paper
• Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

  2001influential reference
• Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR)

  2001cited by this paper
• Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.

  2001influential reference
• A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.

  2001cited by this paper
• Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

  2001cited by this paper
• Pharmacotherapy of attention deficit hyperactivity disorder.

  2000cited by this paper
• Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

  2000cited by this paper
• Der Fremdbeurteilungsbogen für hyperkinetische Störungen (FBB-HKS) - Prävalenz hyperkinetischer Störungen im Elternurteil und psychometrische Kriterien

  2000influential reference
• Comorbidity

  2000cited by this paper
• A double-blind pilot study of risperidone in the treatment of conduct disorder.

  2000cited by this paper
• A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.

  2000cited by this paper
• Inner city disadvantage and family functioning

  2000cited by this paper
• A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct Disorder

  2000cited by this paper
• Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.

  1999cited by this paper
• Comorbidity.

  1999cited by this paper
• Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.

  1999cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• Peptides and psychiatry, Part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis.

  1999cited by this paper
• Fluoxetine in Drug-Dependent Delinquents with Major Depression: An Open Trial

  1997cited by this paper
• Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.

  1997influential reference
• Lithium treatment of conduct disorders in adolescents.

  1997cited by this paper
• Plasma cortisol and aggression in boys with ADHD.

  1997cited by this paper
• Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.

  1996cited by this paper
• Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.

  1996cited by this paper
• Hyperactivity and conduct problems as risk factors for adolescent development.

  1996cited by this paper
• Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.

  1996cited by this paper
• Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study.

  1995cited by this paper
• Treatment of aggressive children with clonidine: results of an open pilot study.

  1993cited by this paper
• A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response.

  1993cited by this paper
• [Indications for clonidine in child psychiatry].

  1993cited by this paper
• Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate.

  1992cited by this paper
• Comorbidity for disruptive behavior disorders in psychiatrically hospitalized children

  1992cited by this paper
• Advancing Knowledge About Co-Offending: Results from a Prospective Longitudinal Survey of London Males

  1991cited by this paper
• Attention Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment

  1991cited by this paper
• Straight and devious pathways from childhood to adulthood.

  1990cited by this paper
• Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings.

  1990cited by this paper
• Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report.

  1990cited by this paper
• Oppositional disorder in children: a validation study comparing conduct disorder, oppositional disorder and normal control children.

  1990cited by this paper
• Long-term criminal outcomes of hyperactivity-impulsivity-attention deficit and conduct problems in childhood.

  1990cited by this paper
• The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate.

  1989cited by this paper
• Statistical Power Analysis for the Behavioral Sciences (2nd ed.)

  1989influential reference
• ADDH and conduct disorder: degree of diagnostic overlap and differences among correlates.

  1989cited by this paper
• A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.

  1989cited by this paper
• Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.

  1988cited by this paper
• Oppositional disorder: fact or fiction?

  1988cited by this paper
• Offensive and defensive aggression in humans: a longitudinal perspective

  1987cited by this paper
• Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children.

  1987cited by this paper
• Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity.

  1987cited by this paper
• Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder.

  1987cited by this paper
• Attention deficit, conduct, oppositional, and anxiety disorders in children: II. Clinical characteristics.

  1987cited by this paper
• Molindone hydrochloride treatment of hospitalized children with conduct disorder.

  1985cited by this paper
• Pemoline Pharmacokinetics and Long Term

  1985cited by this paper
• Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.

  1984cited by this paper
• A Four-Year Follow-up of Hyperactive Boys with and without Conduct Disorder

  1983cited by this paper
• Drugs in aggressive behavior.

  1982cited by this paper
• The characteristics of situationally and pervasively hyperactive children: implications for syndrome definition.

  1981cited by this paper
• Hyperactive and aggressive behaviors in childhood: Intertwined dimensions

  1981cited by this paper
• Hyperkinetic/aggressive boys in treatment: predictors of clinical response to methylphenidate.

  1978cited by this paper
• The hyperkinetic syndrome.

  1973cited by this paper
• Treatment of young delinquent boys with diphenylhydantoin sodium and methyphenidate. A controlled comparison.

  1971cited by this paper
• A PSYCHOPHARMACOLOGIC EXPERIMENT IN A TRAINING SCHOOL FOR DELINQUENT BOYS

  1963cited by this paper

• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  2025cites this paper
• The effect of a single dose of methylphenidate on attention in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder

  2024cites this paper
• ADHD medication adherence reduces risk of committing minor offenses in adolescents.

  2024cites this paper
• Oppositional Defiant Disorder: Clinical Considerations and When to Worry.

  2024cites this paper
• Psychopharmacological treatment of disruptive behavior in youths: systematic review and network meta-analysis

  2023cites this paper
• Impulsive aggression: recognition and choice of pharmacotherapy

  2023cites this paper
• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  2023cites this paper
• Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD

  2022cites this paper
• Assessing and treating aggression in children and adolescents

  2021cites this paper
• Disruptive, Impulse-Control, and Conduct Disorders: Prognosis, Assessment, and Treatment of Youth “Grown-Up”

  2021cites this paper
• Methylphenidate reduces anxiety and dose dependently affects aggression and sustained attention in BALB/cJ mice

  2019cites this paper
• Comparative Efficacy of Methylphenidate and Atomoxetine on Emotional and Behavioral Problems in Youths with Attention-Deficit/Hyperactivity Disorder

  2019cites this paper
• Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD

  2019cites this paper
• References

  2019cites this paper
• Current pharmacotherapy options for conduct disorders in adolescents and children

  2019cites this paper
• High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder

  2019cites this paper
• The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder

  2018cites this paper
• The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODD

  2018cites this paper
• Methylphenidate induced acute psychosis in a case with mild intellectual disability and ADHD

  2018cites this paper
• Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder

  2018cites this paper
• Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005–2013

  2018influential citation
• Short-term efficacy and tolerability of methylphenidate in children with traumatic brain injury and attention problems.

  2017cites this paper
• The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous—unemotional traits modulate the efficacy of medication?

  2017cites this paper
• Biochemical Imbalances and Micronutrient Intervention in Violent and Aggressive Male Children and Adolescents

  2017influential citation
• Declines in prevalence of adolescent substance use disorders and delinquent behaviors in the USA: a unitary trend?

  2017cites this paper
• Pharmacotherapy of conduct disorder: Challenges, options and future directions

  2016influential citation
• Clock genes, ADHD and aggression

  2016cites this paper
• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  2015cites this paper
• The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Meta-Analysis. Part 1: Psychostimulants, Alpha-2 Agonists

  2015cites this paper
• Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder

  2015cites this paper
• Toward Quality Care in ADHD

  2015cites this paper
• Attention-Deficit/Hyperactivity Disorders

  2014cites this paper
• The attention deficit hyperactivity disorder phenotype as a summation of deficits in executive functioning and reward sensitivity: does this explain its relationship with oppositional defiant disorder?

  2014cites this paper
• Medication for Attention Deficit–Hyperactivity Disorder and Criminality

  2014cites this paper
• Pharmacological and clinical dilemmas of prescribing in co‐morbid adult attention‐deficit/hyperactivity disorder and addiction

  2014cites this paper
• Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

  2013cites this paper
• An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate

  2013cites this paper
• Medication for attention deficit-hyperactivity disorder and criminality.

  2013cites this paper
• Oppositional Defiant Disorder in Adults With ADHD

  2013cites this paper
• Metylofenidat (Medikinet) w leczeniu zespołu ADHD – opinie lekarzy na podstawie badania metodą delficką

  2013cites this paper
• A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment

  2013cites this paper
• The impact of a multimodal Summer Camp Training on neuropsychological functioning in children and adolescents with ADHD: An exploratory study

  2012cites this paper
• ADHD in children and adolescents.

  2011cites this paper
• Time to redefine the diagnosis of oppositional defiant disorder

  2011cites this paper
• Environmental Enrichment Preceding Early Adulthood Methylphenidate Treatment Leads to Long Term Increase of Corticosterone and Testosterone in the Rat

  2011cites this paper
• Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder

  2011cites this paper
• Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany

  2011cites this paper
• Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

  2011cites this paper
• What can actigraphy add to the concept of labschool design in clinical trials?

  2010cites this paper
• [Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-morbidities].

  2010cites this paper
• Medikamentöse Behandlungsalgorithmen bei Aufmerksamkeitsdefizit- Hyperaktivitätsstörungen unter Berücksichtigung spezifischer Komorbiditäten

  2010cites this paper
• Impulsive aggression in adults with attention‐deficit/hyperactivity disorder

  2010cites this paper
• A current update on ADHD pharmacogenomics.

  2010cites this paper
• MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder.

  2009cites this paper
• Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

  2009cites this paper
• Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study

  2009cites this paper
• Treating the childhood bipolar controversy: a tale of two children.

  2009cites this paper
• Aufmerksamkeits-Defizit-Hyperaktivitäts-Störungen

  2009cites this paper
• [Pharmacological treatment of impulsivity and aggressive behavior].

  2009cites this paper
• Attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder or conduct disorder

  2009cites this paper
• Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms

  2009cites this paper
• InforMatrix for attention deficit hyperactivity disorder

  2009cites this paper
• InforMatrix for attention deficit hyperactivity disorder.

  2009cites this paper
• ADHD in children and adolescents.

  2008cites this paper
• Current awareness in human psychopharmacology

  2008cites this paper